Source: CNBC

Ro: Ro to offer lower-price vials of weight loss drug Zepbound by teaming up with Eli Lilly

It is made possible through a first-of-a-kind integration with Eli Lilly's direct-to-consumer website, and aims to streamline access to the popular treatment.

Read full article »
Est. Annual Revenue
$100-500M
Est. Employees
500-1.0K
Zachariah Reitano's photo - Co-Founder & CEO of Ro

Co-Founder & CEO

Zachariah Reitano

CEO Approval Rating

90/100

Read more